ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2026
Targeting Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs): A Novel Therapeutic Strategy for Diabetic Complications.
Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenesis of diabetes mellitus and its complications involves multiple factors and complex mechanisms. Currently, clinical treatment options remain limited, posing an ongoing and severe challenge to global public health. Therefore, in-depth research and understanding are urgently needed to advance the development of therapeutic strategies. Extensive studies have indicated that the endoplasmic reticulum (ER) and mitochondria are key organelles driving the occurrence and progression of diabetes mellitus and its complications. Notably, the mitochondria-associated endoplasmic reticulum membranes (MAMs), serving as a physical and functional bridge connecting the ER and mitochondria, play a critical role in maintaining organelle functional homeostasis, which underscores the importance of inter-organelle communication. This review systematically summarizes the integrated structure and regulatory mechanisms of MAMs, as well as their physiological functions in mediating inter-organelle signal transduction and material exchange. Furthermore, it elaborates in detail on the diverse pathogenic roles of MAMs dysfunction in diabetes mellitus and its complications, with a focus on its involvement in calcium signaling, lipid synthesis and transport, mitochondrial dynamics, cellular stress, and cell death. In addition, this review specifically points out that multi-component and multi-target holistic regulatory strategies exhibit unique potential in restoring MAMs homeostasis, thereby providing novel perspectives and potential preclinical intervention approaches for the "holistic regulation" treatment of diabetes complications. In conclusion, clarifying the role of MAMs in diabetes mellitus and its complications is expected to lay an important theoretical foundation for the development of preclinical therapeutic strategies, although significant challenges remain for clinical translation, including tissue-specific targeting, safety, and the lack of validated biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.